HBV polymerase (455 – 463)

<p>HBV polymerase (455-463) is a high-purity, research-grade peptide for the study of hepatitis B virus (HBV) biology and antiviral development. The product's full specifications, including CAS number, molecular formula, and molecular weight, are detailed in the technical data sheet and certificate of analysis (COA). This HLA-restricted epitope is designed to support immunological and virological research.<br/><…

SupplierGlobal Technology Co., Ltd.www.hqtechtirz.com

View on supplier website More from this supplier

Source categories

Peptides

About this product

Product information from the supplier.

TECHNICAL SPECIFICATIONS

Item	Specification
Product Name	HBV polymerase (455-463)
CAS NO.
Appearance	White to off-white lyophilized powder
Molecular Formula	C46H79N15O12
Molecular Weight	1034.24/mol
Amino Acid Sequence	FLPSDFFPSV (HBV polymerase residues 455-463, HLA-A*0201-restricted epitope)
Purity (RP-HPLC)	≥95.0%
Solubility	Soluble in DMSO, PBS, or sterile water (may require brief sonication)
Endotoxin	≤1.0 EU/mg
Biological Activity	HLA-A*0201-restricted cytotoxic T lymphocyte (CTL) epitope derived from Hepatitis B virus polymerase; used in immunotherapy research, T-cell activation studies, and vaccine development for HBV infection.
Storage Conditions	Store at –20°C, protected from light and moisture. For long-term storage, recommend –80°C.
Stock Location	Stock in USA
MOQ	10mg

1.MECHANISM OF ACTION

HBV polymerase (455-463) acts as a HLA-A*0201-restricted cytotoxic T lymphocyte (CTL) epitope derived from the viral polymerase. When processed and presented by antigen-presenting cells, it activates virus-specific CTLs, which can recognize and eliminate HBV-infected hepatocytes, thereby contributing to a targeted antiviral immune response.

2.PRODUCT INDICATIONS

This peptide is used in HBV immunotherapy research, T-cell activation studies, epitope mapping, and the development of therapeutic vaccines. It is also applied in immunological assays and preclinical studies evaluating adaptive immune responses against HBV infection.

3.CLINICAL EFFICACY OF PRODUCT

Preclinical studies indicate that peptides targeting HBV polymerase can elicit strong, virus-specific T-cell responses in model systems. While this epitope itself is not a direct therapeutic, its immunogenic properties support its use as a tool for developing and evaluating HBV-specific immunotherapies and vaccine candidates.

4.DELIVERY & SHIPPING

We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
Professional and Secure Packaging
Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
We can also customize packaging according to customer needs.
Shipping Methods
Main Method: International Air Freight

We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.